94729-09-6

Basic information

• Product Name: bromobenzarone
• Synonyms: bromobenzarone;(3-BroMo-4-hydroxyphenyl)(2-ethyl-3-benzofuranyl)-Methanone;(3-bromo-4-hydroxyphenyl)-(2-ethyl-1-benzofuran-3-yl)methanone
• CAS NO: 94729-09-6
• Molecular Formula: C₁₇H₁₃BrO₃
• Molecular Weight: 345.19
• Mol File: 94729-09-6.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 498.1°Cat760mmHg
• Flash Point: 255.1°C
• Appearance: /
• Density: 1.488g/cm³
• Vapor Pressure: 1.51E-10mmHg at 25°C
• Refractive Index: 1.657
• PKA: 6.18±0.20(Predicted)
• CAS DataBase Reference: bromobenzarone(CAS DataBase Reference)
• NIST Chemistry Reference: bromobenzarone(94729-09-6)
• EPA Substance Registry System: bromobenzarone(94729-09-6)

Safety Data

• Hazardous Substances Data: 94729-09-6(Hazardous Substances Data)

Usage

General Description

Bromobenzarone is a chemical compound with the formula C13H8BrNO. It belongs to the class of aromatic ketones and contains a bromine atom attached to a benzene ring. This chemical is used as a precursor in the synthesis of pharmaceutical compounds and has been studied for its potential therapeutic applications. It has also been investigated for its potential environmental impact and toxicity. Bromobenzarone is a key intermediate in the production of various biologically active molecules and is of interest to researchers in the fields of medicinal chemistry and drug discovery.

InChI:InChI=1/C17H13BrO3/c1-2-14-16(11-5-3-4-6-15(11)21-14)17(20)10-7-8-13(19)12(18)9-10/h3-9,19H,2H2,1H3

Upstream product

• 100-52-7 benzaldehyde 
• 3131-63-3 2-ethylbenzofuran 
• 1646-26-0 1-(benzo[b]furan-2-yl)ethanone 
• 1352799-79-1 (3-bromo-4-methoxyphenyl)(2-ethylbenzofuran-3-yl)methanone 
• 90-02-8 salicylaldehyde 

Relevant articles and documents

DEVELOPING POTENT URATE TRANSPORTER INHIBITORS: COMPOUNDS DESIGNED FOR THEIR URICOSURIC ACTION

A compound represented by the general Formula (I): a pharmaceutically acceptable salt or ester thereof, a solvate thereof, a chelate thereof, a non-covalent complex thereof, a pro-drug thereof, a deuterated radio-labeled analog thereof, and mixtures of any of the foregoing, wherein: A - K are individually selected from carbon or nitrogen; X = -O, -NR1,or -S; R1-11 are individually selected from the group consisting of-H, C1-C6 alkyl, C6-C aryl, substituted C6-C14 aryl, C1-C14-alkoxy, halogen, hydroxyl, carboxy, cyano, C1-C6-alkanoyloxy, C1-C6-alkylthio, C1-C6-alkylsulfonyl, trifluoromethyl, hydroxy, C2-C6-alkoxycarbonyl, C2-C6-alkanoylamino, -O-R12, S-R12,-SO2-Ri2, -NHSO2R12 and -NHCO2R12, wherein R12 is phenyl, naphthyl, or phenyl or naphthly substituted with one to three groups selected from C1-C6-alkyl, C6-C10 aryl,C1-C6-alkoxy and halogen, and C4-C20 hydroxyheteroaryl wherein the heteroatoms are selected from the group consisting of sulfur, nitrogen, and oxygen.